Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 10, 2018
Inceptua Group announces that Maria Eklind-Cervenka joins as new Chief Medical Officer (CMO).
read more
Tuesday, October 09, 2018
BioDuro has established a new drug discovery center for chemistry and biology in San Diego, CA.
read more
Tuesday, October 09, 2018
Recipharm has released its first serialized products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden.
read more
Tuesday, October 09, 2018
The license grants Memorial Sloan Kettering rights to research, develop and commercialize, with rights to sub-license, certain AlivaMab antibodies against a specific target.
read more
Tuesday, October 09, 2018
Lonza announced an expansion of its highly potent API capacity for the specific support of antibody drug conjugate payload manufacturing.
read more
Tuesday, October 09, 2018
Supply Chain Wizard and Epista Life Science ApS have partnered to support their clients beyond serialization compliance deadlines.
read more
Lonza announced an expansion of its highly potent API (HPAPI) capacity for the specific support of antibody drug conjugate (ADC) payload manufacturing.
read more
Sarepta has entered into a long-term strategic manufacturing partnership with Paragon, which will provide access to additional commercial manufacturing capacity for its micro-dystrophin DMD gene therapy program.
read more
Klöckner Pentaplast’s Pharma & Medical Device Division announced it will add to its global production capacity in North America.
read more
Cambrex announced that it is investing approximately $3 million to increase the capacity and efficiency of one of its cGMP manufacturing facilities at its site in Paullo, Milan, Italy.
read more
Whitehouse Labs has expanded impurity testing capacity in its Lebanon, NJ, facility with the addition of an Agilent 7900 ICP-MS (inductively coupled plasma mass spectrophotometer) system.
read more
Trans-Hit Bio announced the signing of an exclusive partnership with Professor Hugo A. Barrera-Saldaña, Founder and General Director of Vitagenesis, the first Mexican biomarker-based diagnostic laboratory.
read more
Therapure Biomanufacturing announced approval for the manufacturing of Insmed’s Arikayce at its Mississauga facility by the FDA.
read more
Hitachi Chemical Advanced Therapeutics Solutions (HCATS) announced they have signed a three-year clinical manufacturing agreement with GSK, a science-led global healthcare company
read more
Samsung BioLogics announced on October 1st, 2018 that its Plant 3 has become cGMP ready and started production (OOF, out of freezing) after its successful validation.
read more